Citations

Showing 10 of 108104 citations.

Effectiveness of Interventions for Weight Loss for People With Serious Mental Illness: A Systematic Review and Meta-Analysis
Brown, Catana , Geiszler, Lydia C., Lewis, Kelsie J., Arbesman, Marian

Mayo Clinic

American Journal of Occupational Therapy | August 9, 2018 | Volume: 72 | Issue: 5 | Pages: 638-647

10.5014/ajot.2018.033415 | PMID 30157007 Get It

OBJECTIVE. We examined the effectiveness of weight loss interventions in community-based settings for people with serious mental illness (SMI). METHOD. Four databases were searched for randomized controlled trials published in 2008 or later that met the criteria for the research question and used weight loss as an outcome measure. Data were extracted, and weight loss was analyzed using a meta-analysis. Similarities and differences in interventions were analyzed qualitatively. RESULTS. Seventeen studies and a total of 1,874 participants with various diagnoses of SMI were included in the meta-analysis. The various lifestyle-focused interventions had a significant effect on weight loss with an overall effect size of −0.308 ( p < .001). CONCLUSION. Community-based interventions for people with SMI are effective for weight loss. Occupational therapists can be involved in the provision of weight loss interventions and in the development and study of intervention components that are most effective.
Using Stress Ultrasonography to Understand the Risk of UCL Injury Among Professional Baseball Pitchers Based on Ligament Morphology and Dynamic Abnormalities
Shanley, Ellen , Smith, Matthew V. , Mayer, Braden K. , Bailey, Lane , Tokish, John M. , Kissenberth, Michael J. , Noonan, Thomas J. , Thigpen, Charles A.

Mayo Clinic

Orthopaedic Journal of Sports Medicine | August 9, 2018 | Volume: 6 | Issue: 8 | Pages: No page available

10.1177/2325967118788847 | PMID 30116762 Get It

Background: Ulnar collateral ligament (UCL) injury of the elbow is a common and debilitating problem seen frequently among elite baseball pitchers. Ultrasound is a useful diagnostic tool in evaluating UCL injuries. Hypothesis: Evaluation with stress ultrasound of the elbow to measure the morphology of the UCL and the ulnohumeral joint space gapping is indicative of higher risk of UCL injury among professional baseball pitchers. Study Design: Cohort study; Level of evidence, 2. Methods: Ultrasound imaging was used to assess the medial joint laxity of the elbow of 70 asymptomatic professional baseball pitchers during spring training. Medial joint laxity and UCL morphology were assessed with OsiriX imaging software under 2 conditions—gravity valgus load and 5.5 lb of valgus load per a handheld dynamometer—with the shoulder in the maximal cocking position and the elbow in 90° of flexion. Two trials of resting position, elbow gapping, and UCL thickness were collected, measured, and averaged for data analysis. Intra- and interrater reliabilities were established and maintained, with intraclass correlation coefficients in the acceptable range for all measures (0.84-0.99). One-way analysis of variance was used to compare dominant variables between those pitchers who sustained a subsequent UCL injury and those who did not. A receiver operating curve was used to identify pitchers who, based on elbow gapping measures (by cut score), were at high risk versus low risk for UCL injury. Results: Players who went on to injure the UCL (n = 7) displayed a significantly wider opening under 5.5 lb of applied stress (6.5 ± 1.2 vs 5.3 ± 1.2 mm, P = .01) when compared with pitchers without UCL injury history (n = 63); they also presented a trend toward wider dominant arm resting joint opening (4.9 ± 1.2 vs 4.0 ± 1.1 mm, P = .07). Professional pitchers with valgus stress ulnohumeral joint gapping ≥5.6 mm (area underneath the curve, 0.77; P = .02) of the dominant arm were at a 6-times greater risk of sustaining a UCL tear requiring reconstruction within a season. Conclusion: Our data suggest that ultrasound evaluation of UCL morphology may be indicative of pitchers who are at risk of sustaining UCL injury and that it may improve player assessment.
Acute serous tamponade after paraesophageal hernia repair reoperation
Makey, Ian A. , Beers, Kevin , Eilers, Amanda L., Thomas, Mathew

Mayo Clinic

BMJ Case Reports | August 9, 2018 | Volume: 2018 | Issue: No issue available | Pages: bcr-2018-225466

10.1136/bcr-2018-225466 | PMID 30093469 Get It

Cardiac tamponade is a common complication after cardiac surgery and is usually caused by bleeding or thrombus in the early postoperative period. Postoperative serous tamponade is more rare and usually of gradual onset. We report an unusual and life-threatening case of serous tamponade occurring on postoperative day 1 following a third-time paraesophageal hernia repair.
Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma
DuBois, Steven G. , Mossé, Yaël P. , Fox, Elizabeth , Kudgus, Rachel A. , McGovern, Renee M., Groshen, Susan , Maris, John M. , Twist, Clare J. , Goldsmith, Kelly C. , Granger, Meaghan , Macy, Margaret E. , Yanik, Greg, Wagner, Lars M. , Hawkins, Randall A., Courtier, Jesse , Lai, Hollie , Boucher, Najee, Czarnecki, Scarlett, Luo, Chunqiao, Marachelian, Araz , Reid, Joel M. , McGovern, Renee, Groshen, Susan , Maris, John M , Weiss, Brian , Cohn, Susan L , Courtier, Jesse , Bagatell, Rochelle , Park, Julie R. , Cohn, Susan L. , Goodarzian, Fariba , Shimada, Hiroyuki , Tsao-Wei, Denice D , Matthay, Katherine K.

Mayo Clinic

Clinical Cancer Research | August 9, 2018 | Volume: 24 | Issue: 24 | Pages: 6142-6149

10.1158/1078-0432.ccr-18-1381 | PMID 30093449 Get It

Abstract Purpose: In phase I testing, alisertib tablets with irinotecan and temozolomide showed significant antitumor activity in patients with neuroblastoma. This study sought to confirm activity of this regimen; evaluate an alisertib oral solution; and evaluate biomarkers of clinical outcomes. Patients and Methods: We conducted a two-stage phase II trial of alisertib tablets (60 mg/m2/dose × 7 days), irinotecan (50 mg/m2/dose i.v. × 5 days), and temozolomide (100 mg/m2/dose orally × 5 days) in patients with relapsed or refractory neuroblastoma. The primary endpoint was best objective response. A separate cohort was treated with alisertib at 45 mg/m2 using oral solution instead of tablets. Exploratory analyses sought to identify predictors of toxicity, response, and progression-free survival (PFS) using pooled data from phase I, phase II, and oral solution cohorts. Results: Twenty and 12 eligible patients were treated in the phase II and oral solution cohorts, respectively. Hematologic toxicities were the most common adverse events. In phase II, partial responses were observed in 19 evaluable patients (21%). The estimated PFS at 1 year was 34%. In the oral solution cohort, 3 patients (25%) had first cycle dose-limiting toxicity (DLT). Alisertib oral solution at 45 mg/m2 had significantly higher median Cmax and exposure compared with tablets at 60 mg/m2. Higher alisertib trough concentration was associated with first cycle DLT, whereas MYCN amplification was associated with inferior PFS. Conclusions: This combination shows antitumor activity, particularly in patients with MYCN nonamplified tumors. Data on an alisertib oral solution expand the population able to be treated with this agent.
Hypoxia-Inducible Factor 2α: A Novel Target in Gliomas
Renfrow, Jaclyn J. , Soike, M. , Debinski, Waldemar, Ramkissoon, Shakti, Mott, Ryan T., Frenkel, Mark B. , Lesser, Glenn J. , Strowd, Roy E. , Sarkaria, Jann N. , Strowd, Roy E

Mayo Clinic

Future Medicinal Chemistry | August 9, 2018 | Volume: 10 | Issue: 18 | Pages: 2227-2236

10.4155/fmc-2018-0163 | PMID 30089425 Get It

Melatonin modulates autophagy and inflammation protecting human placental trophoblast from hypoxia/reoxygenation
Sagrillo‐Fagundes, Lucas , Salustiano, Eugênia Maria Assunção , Vaillancourt, Cathy , Vaillancourt, Cathy , Ruano, Rodrigo , Markus, Regina P.

Mayo Clinic

Journal of Pineal Research | August 9, 2018 | Volume: 65 | Issue: 4 | Pages: No page available

10.1111/jpi.12520 | PMID 30091210 Get It

AbstractMelatonin has been proposed as a possible treatment for the deleterious effects of hypoxia/reoxygenation (H/R), such as autophagy, inflammation, and apoptosis. Pathological pregnancies, such as preeclampsia, are associated with placental H/R, and decreased placental melatonin synthesis as well as lower melatonin levels in the placenta and maternal plasma. However, the effects of exogenous melatonin on inflammation and autophagy induced by pregnancy complications associated with H/R await investigation. This study aimed to determine as to whether melatonin protects human primary villous trophoblasts against H/R‐induced autophagy, inflammation, and apoptosis. Human primary villous cytotrophoblasts were isolated and immunopurified from normal term placentas. These cells were then exposed or not to 1 mmol/L melatonin for 72 hour in normoxia (8% O2), thereby inducing differentiation into syncytiotrophoblast that was then exposed to H/R (0.5% O2, for 4 hour) or normoxia. H/R decreased endogenous melatonin synthesis (by 68%) and interleukin (IL)‐10 levels (by 72%), coupled to increased tumor necrosis factor (TNF) (by 114%), IL‐6 (by 55%), and NFκB (by 399%), compared to normoxia. Melatonin treatment reversed the H/R effect, restoring IL‐10, TNF, and IL‐6 levels to those of the normoxia condition. Melatonin, as well as NFκB inhibition, enhanced autophagy activation, consequently increasing syncytiotrophoblast survival in H/R conditions. This study suggests that H/R, which is present in pregnancy complications, inhibits endogenous melatonin production, thereby contributing to reduced syncytiotrophoblast viability. Results indicate that exogenous melatonin treatment may afford protection against H/R‐induced damage, thereby enhancing placental cell survival, and contributing to improved fetal outcomes.
How early can we diagnose Alzheimer disease (and is it sufficient)?
Petersen, Ronald C.

Mayo Clinic

Neurology | August 8, 2018 | Volume: 91 | Issue: 9 | Pages: 395-402

10.1212/wnl.0000000000006088 | PMID 30089620 Get It

Sex-specific gene and pathway modeling of inherited glioma risk
Ostrom, Quinn T. , COLEMAN, WARREN, Lathia, Justin D. , Liao, Peter, Wrensch, Margaret , Eckel‐Passow, Jeanette E. , Armstrong, Georgina , Rice, Terri, McCoy, Lucie , Hansen, Helen M. , Bernstein, Jonine L. , Claus, Elizabeth B. , Houlston, Richard S. , Jenkins, Robert B. , Johansen, Christoffer , Lai, Rose , Merrell, Ryan , Sadetzki, Siegal , Schildkraut, Joellen M. , Shete, Sanjay , Andersson, Ulrika , Rajaraman, Preetha , Linet, Martha S. , Wang, Zhaoming , Bracci, Paige M. , Molinaro, Annette M. , Pezmecki, M, Prados, Michael D. , Smirnov, Ivan, Wiemels, Joseph L. , Zheng, Shichun, Visvanathan, Kala , Stevens, Victoria L. , Henriksson, Roger , Feychting, Maria , Ahlbom, Anders , Milne, Graham G Giles Roger, McKean‐Cowdin, Roberta , Stampfer, Meir J. , Ruder, Avima M., Hallmans, Göran , Gaziano, J. Michael , Sesso, Howard D. , Purdue, Mark P. , Peters, Ulrike , Buring, Julie E. , Melin, Beatrice , Bondy, Melissa L. , Barnholtz‐Sloan, Jill S. , Houlston, Richard S , Barnholtz-Sloan, Jill S , Wang, Zhaoming , Visvanathan, Kala , Coleman, Warren, Huang, William Y. C. , Rubin, Joshua B , Berens, Michael E. , Speyer, Gil , Armstrong, Georgina , Wiencke, John K. , Amos, Christopher I. , Il’yasova, Dora , Lachance, Daniel Honore , Olson, Sara H. , Chanock, Stephen Jacob , Yeager, Meredith , Berger, Mitchel S. , Chang, Stephen , Clarke, Jennifer , Molinaro, Annette M. , Perry, Arie , Tihan, Tarık , Walsh, Kyle M. , Freeman, Laura E. Beane , Koutros, Stella , Albanes, Demetrius , Michaud, Dominique S. , Marchand, Loı̈c Le , Carreón, Tania , Zeleniuch‐Jacquotte, Anne , White, Emily , Ostrom, Quinn T

Mayo Clinic

Neuro-Oncology | August 8, 2018 | Volume: 21 | Issue: 1 | Pages: 71-82

10.1093/neuonc/noy135 | PMID 30124908 Get It

Multiparametric MRI detects longitudinal evolution of folic acid-induced nephropathy in mice
Jiang, Kai , Ponzo, Tristan A., Tang, Hui , Mishra, Prasanna K. , Lerman, Lilach O. , Macura, Slobodan I, Macura, Slobodan

Mayo Clinic

American Journal of Physiology-Renal Physiology | August 8, 2018 | Volume: 315 | Issue: 5 | Pages: F1252-F1260

10.1152/ajprenal.00128.2018 | PMID 30089037 Get It

The rodent model of folic acid (FA)-induced acute kidney injury (AKI) provides a useful model for studying human AKI, but little is known about longitudinal changes in renal hemodynamics and evolution of renal fibrosis in vivo. In this work, we aimed to longitudinally assess renal structural and functional changes using multiparametric magnetic resonance imaging (MRI). Ten adult mice were injected with FA, after which a multiparametric MRI was used to measure kidney volume, hypoxia index R2*, magnetization transfer ratio (MTR), perfusion, T1, and glomerular filtration rate (GFR) at 2 wk posttreatment. Then five mice were euthanized for histology, and the other five underwent MRI again at 4 wk, followed by histology. Control mice ( n = 5) were injected with vehicle and studied with MRI at 2 wk. Trichrome and hematoxylin-eosin staining were performed to assess FA-induced tissue injuries. Whereas kidney size and oxygenation showed progressive deterioration, a transient impairment in renal perfusion and normalized GFR slightly improved by 4 wk. Kidney fluid content, as reflected by T1, was prominent at 2 wk and tended to regress at 4 wk, consistent with observed tubular dilation. Trichrome staining revealed patchy necrosis and mild interstitial fibrosis at 2 wk, which exacerbated at 4 wk. MTR detected increased fibrosis at 4 wk. In conclusion, multiparametric MRI captured the longitudinal progression in kidney damage evolving within the first month after treatment with folic acid and may provide a useful tool for assessment of therapeutic strategies.
Multi-ingredient pre-workout supplements, safety implications, and performance outcomes: a brief review
Harty, Patrick S. , Zabriskie, Hannah A. , Erickson, Jacob L. , Molling, Paul , Jagim, Andrew R. , Molling, Paul E, Jagim, Andrew R , Harty, Patrick S , Zabriskie, Hannah A , Kerksick, Chad M.

Mayo Clinic

Journal of the International Society of Sports Nutrition | August 8, 2018 | Volume: 15 | Issue: 1 | Pages: No page available

10.1186/s12970-018-0247-6 | PMID 30089501 Get It